Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course (Sept 23, 2025)" training has been added to ...
For the first time, two Chinese companies make the EPO Top 10: CATL moves up to 10th (from 14th in 2024) MUNICH, April 2, 2026 /PRNewswire/ -- Chinese companies and inventors filed a record 22,031 ...
On Tuesday, the European Patent Office (EPO) published the Patent Index 2024, the latest edition of the EU patent agency’s annual snapshot into global innovation through the lens of European patent ...
Law360, London (October 22, 2024, 7:10 PM BST) -- Universities on the hunt for "academic patents" are behind a rising proportion of all applications made to the European Patent Office, the agency said ...
“While EU entities led the collective number of unitary patents registered by the EPO, U.S.-based medical technology company Johnson & Johnson (J&J) led all individual entities.” On June 1, one year ...
Practitioners from in-house and academia, as well as a judge at the Unified Patent Court, outlined why high-quality patents are so important for legal certainty amid some concern that the EPO is ...
Beginning in October 2025, the European Patent Office (EPO) will accept patent drawings in color or grayscale when filed electronically.[1] By allowing more detailed and visually accurate ...
Companies including Siemens, Bayer and Ericsson say they just want ‘thorough and complete’ examinations after an EPO memo suggests an ‘arbitrary’ reallocation of applications A group of in-house ...
Halozyme (HALO) provided an update following a decision by the Opposition Division of the European Patent Office, or EPO, to revoke one of the Janssen Biotech (JNJ) co-formulation patents for Darzalex ...
The European Patent Office has reportedly upheld the validity of Moderna’s (NASDAQ:MRNA) 949 patent for its COVID-19 vaccine in an ongoing dispute between the company and rival vaccine makers Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results